1. Home
  2. FRST vs EDIT Comparison

FRST vs EDIT Comparison

Compare FRST & EDIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primis Financial Corp.

FRST

Primis Financial Corp.

HOLD

Current Price

$16.18

Market Cap

404.3M

Sector

Finance

ML Signal

HOLD

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$3.04

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRST
EDIT
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.3M
432.8M
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
FRST
EDIT
Price
$16.18
$3.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$5.30
AVG Volume (30 Days)
132.9K
2.5M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
2.74%
N/A
EPS Growth
477.27
37.50
EPS
0.68
N/A
Revenue
N/A
$31,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$9.63
N/A
P/E Ratio
$24.09
N/A
Revenue Growth
N/A
132.64
52 Week Low
$9.55
$1.66
52 Week High
$16.88
$4.54

Technical Indicators

Market Signals
Indicator
FRST
EDIT
Relative Strength Index (RSI) 51.51 50.68
Support Level $15.21 $2.74
Resistance Level $16.39 $3.21
Average True Range (ATR) 0.33 0.24
MACD -0.01 -0.00
Stochastic Oscillator 59.22 21.01

Price Performance

Historical Comparison
FRST
EDIT

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

Share on Social Networks: